Current pharmacological solutions for Behcet's syndrome.

Management aims in BS are to preserve function and quality of life, and to avoid damage. Choice of treatment modalities depends on the organs that are actively involved, severity of involvement and prognostic factors. A treat-to-target strategy would help to improve long-term outcomes in BS.